## CPAY: Corpay, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -1.9% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($291.46)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Oppenheimer | $380 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Oppenheimer | up | Outperform |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 60.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- JPMORGAN CHASE & CO: 12.7% (+93.8%)
- Vanguard Group Inc: 11.7% (+0.7%)
- Blackrock Inc.: 9.0% (+0.3%)
- Orbis Allan Gray Ltd: 5.9% (+7.1%)
- Price (T.Rowe) Assoc: 5.5% (-21.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.90 indicates undervaluation relative to growth. Forward P/E 12.3x attractive for 17% earnings growth. Quality metrics strong (ROE 29%, margin 24%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $21.5B |
| Beta | 0.85 |
| 52W Range | $252.84 - $400.81 |
| Short Interest | 3.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.90 |
| Forward P/E | 12.3 |
| Current P/E | 14.4 |
| YoY Growth | 16.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at -1.9% (minimal 5-day change). Below STRENGTH zone by 4.9pp (needs >3.0% for momentum thesis). Below SMA200 (0.97x), long-term trend not supportive. MACD histogram bearish (-1.25), momentum weakening. RSI neutral at 52. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.86% (CS: 15) | Neutral |
| RSI_14 | 52.1 | Neutral |
| MACD Histogram | -1.25 | Bearish |
| vs SMA20 | 0.991x | Below |
| vs SMA50 | 1.049x | Above |
| vs SMA200 | 0.973x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $305.24
- **Stop Loss:** $291.46 (4.5% risk)
- **Target:** $319.02 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 79
- **Position Value:** $24,113.96
- **Portfolio %:** 24.11%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-04 (Est: $5.93)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.64 | $5.70 | +1.0% |
| 2025Q2 | $5.12 | $5.13 | +0.1% |
| 2025Q1 | $4.51 | $4.51 | -0.1% |
| 2024Q4 | $5.35 | $5.36 | +0.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*